SHELTON, CT / ACCESSWIRE / December 23, 2024 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), says that its broad-spectrum antiviral drug candidate NV-387 is the best weapon to ...
We welcome the decision by the UK Joint Committee on Vaccination and Immunisation (JCVI) to broaden the eligibility for the vaccination programme for the Shingrix recombinant herpes zoster vaccine ...